Abstract
The area of drug discovery tools is one of the newest and most important
sectors of pharmaceutical research and development. The term drug discovery
tools usually refers to high-content screening (HCS) and analysis and is
composed of those applications that require sufficient levels of sample
throughput, whereby complex cellular events and phenotypes can be studied.
Elements of drug performance like toxicity and specificity can be established
simultaneously using mixed cell types-primary cells, cell lines, cell
subpopulations. HCS seeks to assess the impact of phenotypic and cellular
changes that are brought about by gene modification (such as with RNA
interference (RNAi) approaches) and/or drug (or compound) treatment. The
purpose of this examination by TriMark Publications is to describe the
specific segments of the global drug discovery tools market. Within this area,
the report covers those segments that are highly active in terms of innovation
and growth. Specifically, this study examines the markets for small lab
equipment all the way up to highly automated, large automated platforms, as
well as accessory equipment such as reagents, supplies and manufacturers'
original equipment manufacturer (OEM) additional equipment.
View Cart
